Abstract
Chronic rhinosinusitis (CRS) with nasal polyps (NP) represents a diverse group of potential etiologies, many of which may be overlapping. The clinical symptoms of NP do not differentiate between etiologies. Symptoms in patients with NP can be categorized by symptom scores from several instruments, although none are specific for NP and none correlate with the extent of objective disease. Sinus CT scans can be categorized by a variety of scoring systems; however, correlation between sinus symptoms and CT findings is generally poor; the most widely utilized is the Lund–Mackay scoring system. NP can be categorized endoscopically by size through several staging systems, which demonstrate intra and interrater concordance, but again without demonstrated correlation to symptoms. Objective verification of symptoms can be performed through nasal airway patency assessment and smell testing. NP can be categorized by the presence of predominant inflammatory cell population into eosinophilic, neutrophilic, and mixed types. Presence of coexisting pathogens such as bacteria or fungus and the inflammatory response (eosinophilic vs. noneosinophilic) can be utilized to further differentiate NP into distinct categories; the significance of categorization in this manner is under investigation. Categorization by severity should reflect objective disease state, medications required for control, and risks of treatment and untreated disease. A NP categorization system that incorporates sinonasal symptoms scores, objective evidence of disease (CT and endoscopic scores), known risk factors for recalcitrant NP disease, and extent of disease control with medical and surgical treatment over time is most likely to accurately assess the severity of NP disease, assist in the patient’s treatment, and facilitate optimal study of NP.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Fokkens W, Lund V, Mullol J (2007) European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 20:1–136
Dixon AE, Sugar EA, Zinreich SJ et al (2009) Criteria to screen for chronic sinonasal disease. Chest 136(5):1324–1332
Davidson TM, Murphy C (1997) Rapid clinical evaluation of anosmia. The alcohol sniff test. Arch Otolaryngol Head Neck Surg 123(6):591–594
Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (2007) Classifying asthma severity and initiating treatment in youths ≥12 years of age and adults. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf
Meltzer EO, Hamilos DL, Hadley JA et al (2006) Rhinosinusitis: developing guidance for clinical trials. Otolaryngol Head Neck Surg 135(5 Suppl):S31–S80
Lund VJ, Kennedy DW (1995) Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol Suppl 167:17–21
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ferguson, B.J., Rizk, H., Ramakrishnan, J., Pant, H. (2010). Categorization of Nasal Polyps. In: Ă–nerci, T., Ferguson, B. (eds) Nasal Polyposis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11412-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-11412-0_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11411-3
Online ISBN: 978-3-642-11412-0
eBook Packages: MedicineMedicine (R0)